“ú–{–òŠw‰ï ‘æ136”N‰ïi‰¡•lj@2016”N3ŒŽ26“ú(“y)E27“ú(“ú)E28“ú(ŒŽ)E29“ú(‰Î)@–k—¢‘åŠw–òŠw•” Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï FAQ

3ŒŽ28“ú(月)@9:00~11:00@F‰ïê パシフィコ横浜 会議センター 3F 311+312
GS03
次世代若手研究者ã®æŒ‘戦ï¼ï½žé›£æ²»æ€§ç–¾æ‚£ã«å¯¾ã™ã‚‹æ–°ãŸãªå‰µè–¬ã‚¹ãƒˆãƒ©ãƒ†ã‚¸ãƒ¼ï½ž
The Challenge of Next-Generation Young Pharmacologists~The Strategy of Drug Discovery and Evolution for Intractable Disease~
オーガナイザー:ç¦é‡ 亮ã€å°¾å´Ž å‹é¦™

GS03-1
セロトニン/5-HT3å—容体を標的ã¨ã—ãŸæ¶ˆåŒ–管炎症制御ã¸ã®å¿œç”¨
Therapeutic targeting of serotonin/5-HT3 receptors in gut inflammation
ƒVƒ“ƒ|ƒWƒXƒg F ○内海 大知ã€æ¾æœ¬ å¥æ¬¡éƒŽã€å¤©ãƒ¶ç€¬ 紀久å­ã€å €æ±Ÿ ä¿Šæ²»ã€åŠ è—¤ 伸一

GS03-2
Cyclophosphamide誘起膀胱炎・膀胱痛マウスã«ãŠã‘る硫化水素/Tåž‹Ca2+ãƒãƒ£ãƒãƒ«ç³»ã®å½¹å‰²â€•ä¸‹éƒ¨å°¿è·¯æ©Ÿèƒ½éšœå®³ã«å¯¾ã™ã‚‹æ–°ãŸãªæ²»ç™‚標的分å­ã¨ã—ã¦ã®å¯èƒ½æ€§â€•
The role of hydrogen sulfide/T-type Ca2+ channel pathway in mice with cyclophosphamide-induced cystitis and bladder pain—Possible novel therapeutic targets for lower urinary tract dysfunction—
ƒVƒ“ƒ|ƒWƒXƒg F ○尾崎 å‹é¦™ã€åªç”° 真帆ã€å·ç•‘ 篤å²

GS03-3
æ–°è¦ç·‘内障治療薬ã¨ã—ã¦ã®ã‚¢ãƒšãƒªãƒ³ã®å¯èƒ½æ€§
Possibility of apelin as the new glaucoma therapeutic agent
ƒVƒ“ƒ|ƒWƒXƒg F â—‹ä½é‡Ž 彰英ã€çŸ³ä¸¸ 侑希ã€å±±å®¤ 晶å­ã€å‰å²¡ é–å•“ã€å‰ç”° 定秋

GS03-4
脳線æ¡ä½“ã¸ã®substance PæŒç¶šæŠ•ä¸Žã«ã‚ˆã‚Šèª˜ç™ºã•ã‚Œã‚‹ç–¼ç—›åˆ¶å¾¡æ©Ÿæ§‹ã®è§£æ˜Ž
Elucidation of nociceptive transmission following continuous infusion of substance P into rat striatum
ƒVƒ“ƒ|ƒWƒXƒg F â—‹ç¦é‡ 亮ã€ä¸­æ‘ 庸è¼ã€æ£®å²¡ 徳光ã€ä»²ç”° 義啓

ŒŸõƒy[ƒW‚É–ß‚é

TOP‚Ö–ß‚é
ƒvƒ‰ƒCƒoƒV[ƒ|ƒŠƒV[‚ɂ‚¢‚Ä
@Copyright (C) Œö‰vŽÐ’c–@l“ú–{–òŠw‰ï